RxDoctor Payments DataLook up a doctor →

Lakeisha Greenfield

Adult Health · Greenville, NCNPI 1912236548

Payments from drug & device makers

$15,264in general payments, 2019–2025

Across 480 payments — averaging $31.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • EMD Serono, Inc.$2K
  • Livanova USA, Inc.$1K
  • Teva Pharmaceuticals USA, Inc.$1K
  • AbbVie$867
  • SK Life Science, Inc.$645
  • UCB, Inc.$584
  • plus $8K from 43 others

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
EMD Serono, Inc.52$2,427
Livanova USA, Inc.9$1,457
Teva Pharmaceuticals USA, Inc.47$1,411
AbbVie(2 entities)69$867
SK Life Science, Inc.18$645
UCB, Inc.19$584
TG Therapeutics, Inc.6$519
Novartis24$517
Acadia Pharmaceuticals Inc10$447
Lundbeck LLC9$393
Neurelis, Inc.6$373
Genentech USA, Inc.7$355
Amgen(2 entities)8$350
Eisai Inc.17$339
Amneal Pharmaceuticals LLC22$328
Argenx US, Inc.7$321
Biohaven Pharmaceuticals, Inc.12$303
Biogen16$283
Lilly USA, LLC17$283
Boston Scientific2$260
Merz Pharmaceuticals, LLC6$258
AstraZeneca(2 entities)9$251
E.r. Squibb & Sons, L.L.C.2$244
Biohaven Pharmaceutical Holding Company Ltd.8$238
Johnson & Johnson8$207
Bristol Myers Squibb4$188
Neurocrine Biosciences, Inc.7$155
Sunovion Pharmaceuticals Inc.9$155
Corium, LLC7$125
Pfizer2$114
Sanofi5$105
Chiesi USA, Inc.2$102
Acorda Therapeutics, Inc5$89
Avion Pharmaceuticals4$82
MDD US Operations, LLC5$75
Abbott1$60
Aquestive Therapeutics, Inc.3$60
Takeda Pharmaceuticals U.S.A., Inc.2$59
GRT US Holding, Inc.2$32
Arbor Pharmaceuticals, Inc.2$32
Adamas Pharmaceuticals, Inc.2$31
Avanir Pharmaceuticals, Inc.1$22
Alnylam Pharmaceuticals Inc.1$20
Otsuka America Pharmaceutical, Inc.1$19
Cala Health, Inc.1$18
Upsher-smith Laboratories LLC1$16
Sumitomo Pharma America, Inc.1$15
Supernus Pharmaceuticals, Inc.1$14
Tanabe Pharma America, Inc.1$13

How this compares

$15,264 in reported general payments places this provider in the 95th percentile of 614 adult health providers in North Carolina.

See all adult health providers in North Carolina →

Medicare billing

Part B allowed, 2024
$46,251
Medicare patients
261
Services billed
396

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other adult health in Greenville

See the full list for North Carolina →

Where these figures come from

Is this you, or does something look wrong? →